Japanese researchers are nearing a major breakthrough in dental medicine with a drug that can regrow human teeth.
Developed by Toregem Biopharma, this state-of-the-art treatment targets the USAG-1 gene, which inhibits tooth growth, enabling new teeth to form from existing buds.
The drug has presented promising results in animal trials, and has paved the way for human clinical trials in 2024, starting with adults with congenital tooth loss.
If successful, this drug could revolutionize dental care, offering a natural alternative to dentures and implants, and potentially becoming available by 2030.
Also read: Chinese scientists announce they have developed a cure for diabetes
Japanese drug
